Clinical Trial Update: Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of lurbinectedin on cardiac repolarization in patients with selected solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: PharmaMar | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2019-02-18